Deferiprone in iron overload.
Hoffbrand
A V
AV
Wonke
B
B
D000380:Agranulocytosis / Q000139:chemically induced; D017321:Clinical Trials, Phase I as Topic; D000077543:Deferiprone; D006801:Humans; D007502:Iron Chelating Agents / Q000009:adverse effects*; D007592:Joint Diseases / Q000139:chemically induced; D010349:Patient Compliance; D011728:Pyridones / Q000009:adverse effects*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone